Literature

Fund Literature

Shareholder Letter April 2017
Annual Report - Osterweis Funds March 2017

News & Views

Advisor Perspectives OSTGX

Read a recent interview with Fund manager James L. Callinan in which he discussed his thoughts on emerging growth stocks and the investment philosophy behind our Emerging Opportunity Fund.

December 2016
Investing in Market Disruptors

Read about how we think investors could benefit from the rapid growth of market innovators while trying to manage the risks of investing in somewhat unproven companies.

December 2016

Regulatory Reports

Summary Prospectus  
Statutory Prospectus - Emerging Opportunity Fund  
Statement of Additional Information - Emerging Opportunity Fund  
XBRL Risk/Return - OSTGX  

Open an Account

After reading the prospectus, please click on the links below to download an application.

Applications & Forms

Annual Report - Osterweis Funds  

Investment Team

Account Access

Email Update

The Osterweis Funds are available by prospectus only. The Funds’ investment objectives, risks, charges and expenses must be considered carefully before investing. The summary and statutory prospectuses contain this and other important information about the Funds. You may obtain a summary or statutory prospectus by calling toll free at (866) 236-0050, or by visiting www.osterweis.com/statpro. Please read the prospectus carefully before investing to ensure the Fund is appropriate for your goals and risk tolerance.

Mutual fund investing involves risk. Principal loss is possible.

The Osterweis Emerging Opportunity Fund may invest in unseasoned companies, which involve additional risks such as abrupt or erratic price movements. The Fund may invest in small and mid-sized companies, which may involve greater volatility than large-sized companies. The Fund may invest in IPOs and unseasoned companies that are in the early stages of their development and may pose more risk compared to more established companies. The Fund may invest in ETFs, which involve risks that do not apply to conventional funds. Higher turnover rates may result in increased transaction costs, which could impact performance. From time to time, the Fund may have concentrated positions in one or more sectors subjecting the Fund to sector emphasis risk including the health care sector, which may be affected by government regulation, restrictions, pricing and other market developments and the technology sector, which tends to be more volatile than the overall market. The Fund may invest in foreign and emerging market securities, which involve greater volatility and political, economic and currency risks and differences in accounting methods. These risks may increase for emerging markets.

While the fund is no-load, management fees and other expenses still apply. Please refer to the prospectus for more information.

Osterweis Capital Management is the adviser to the Osterweis Funds, which are distributed by Quasar Distributors, LLC.

Back to Top